TCAF ETF Analysis: T. Rowe Price Capital | NYSE
Large Blend | NYSE, USA | Market Cap: 8.902m USD | 12M Return: 16% | US87283Q8675 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 21.9M
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 3.3 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
T. Rowe Price Capital Appreciation Equity ETF (TCAF) is a U.S.-listed, non-diversified ETF that invests at least 80% of its net assets in equity securities. The fund typically focuses on large-capitalization U.S. companies, although it is permitted to purchase stocks of any size.
Portfolio exposure may be concentrated in specific sectors, notably information technology and healthcare-two of the largest segments of the U.S. equity market, encompassing industries such as software, semiconductors, pharmaceuticals, and medical devices. Launched on June 14, 2023, TCAF is classified as a Large Blend fund.
- Large cap US equities rally lifts portfolio NAV
- Information technology sector concentration drives fund performance
- T. Rowe Price ETF inflows expand AUM and fee revenue
As of September 27, 2026, the stock is trading at USD 42.72 with a total of 573,246 shares traded. Over the past week, the price has changed by +1.11%, over one month by +0.21%, over three months by +6.48% and over the past year by +15.95%.
Current recommended Stop Loss: 41.80 (which is 2.2% or 2.4 ATR below the current price).
T. Rowe Price Capital has no consensus analysts rating.